07.25.14
Bioheart Inc. has completed the world’s first combination stem cell treatment with Magnum Cell Therapies in Honduras. A patient with congestive heart failure has been treated with a combination of Adipocell (adipose derived stem cells) and Myocell (muscle derived stem cells). Adipocell may help to promote angiogenesis or new blood vessel formation in ischemic tissue while Myocell may help to promote myogenesis or new muscle formation, the company claims. The cells were delivered directly into the damaged areas of the heart using the Myocath catheter.
The patient was treated at the Honduras Medical Center with Managing Director Ricardo Aguilar, M.D. The procedure was led by cardiologists Haroldo Lopez, M.D., and Raul Marenco, M.D.
Kristin Comella, chief scientific officer of Bioheart, attended the case and said, “We are bringing new regenerative therapies to many patients around the world. We believe that this new method of cell combination is the best therapy available to patients suffering from heart failure.”
“Magnum has brought cutting edge regenerative therapies to Honduras,” said Magnum Chief Medical Officer Rene Fiallos, M.D. “We are seeing excellent results so far with stem cell therapy and we are thrilled to expand our services.”
Bioheart develops cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. The company is based in Sunrise, Fla.
The patient was treated at the Honduras Medical Center with Managing Director Ricardo Aguilar, M.D. The procedure was led by cardiologists Haroldo Lopez, M.D., and Raul Marenco, M.D.
Kristin Comella, chief scientific officer of Bioheart, attended the case and said, “We are bringing new regenerative therapies to many patients around the world. We believe that this new method of cell combination is the best therapy available to patients suffering from heart failure.”
“Magnum has brought cutting edge regenerative therapies to Honduras,” said Magnum Chief Medical Officer Rene Fiallos, M.D. “We are seeing excellent results so far with stem cell therapy and we are thrilled to expand our services.”
Bioheart develops cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. The company is based in Sunrise, Fla.